On 12 May 2021
The Board of Sun Pharma Advanced Research Company will meet on 12 May 2021 to consider and evaluate proposals for raising of funds in one or more tranches by way of issue of Equity Shares or Securities/ Warrants convertible into Equity shares of the Company, through permissible modes including by way of Preferential Issue, subject to the receipt of necessary approvals.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
